ELBD.F Stock Overview

An investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. More details

ELBD.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 53.8% per year over past 5 years

Does not have a meaningful market cap ($14M)

Makes less than USD$1m in revenue ($271K)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Elbit Medical Technologies Ltd Competitors

Catheter Precision

NYSEAM:VTAK

US$4.2m

Tenon Medical

NasdaqCM:TNON

US$5.8m

PAVmed

NasdaqCM:PAVM

US$6.8m

QT Imaging Holdings

NasdaqGS:QTI

US$10.2m

Price History & Performance

Summary of share price highs, lows and changes for Elbit Medical Technologies
Historical stock prices
Current Share Price	₪0.05
52 Week High	₪0.05
52 Week Low	₪0.03
Beta	0.23
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	66.67%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ELBD.F	US Medical Equipment	US Market
7D	0%	2.0%	-0.5%
1Y	n/a	9.8%	23.2%

Return vs Industry: Insufficient data to determine how ELBD.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how ELBD.F performed against the US Market.

Price Volatility

Is ELBD.F's price volatile compared to industry and market?
ELBD.F volatility
ELBD.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.2%

Stable Share Price: ELBD.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ELBD.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	486	Ron Hadassi	n/a

Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders.

Elbit Medical Technologies Ltd Fundamentals Summary

How do Elbit Medical Technologies's earnings and revenue compare to its market cap?
ELBD.F fundamental statistics
Market cap	US$3.70m
Earnings (TTM)	-US$14.83m
Revenue (TTM)	US$271.00k

13.6x

P/S Ratio

-0.2x

P/E Ratio

Is ELBD.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ELBD.F income statement (TTM)
Revenue	US$271.00k
Cost of Revenue	US$0
Gross Profit	US$271.00k
Other Expenses	US$15.10m
Earnings	-US$14.83m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.16
Gross Margin	100.00%
Net Profit Margin	-5,471.59%
Debt/Equity Ratio	0%

How did ELBD.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 20:39
End of Day Share Price	2024/11/08 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elbit Medical Technologies Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution